Rvajna you're right the presentation was scratchy at best. Not much new on the table for a company of this size. An evolutionary product that's missed the Covid boat and a couple of cannulae for a long shot application. Still haven't released their flagship product in the US after close to a decade on the market. Maybe the new director will pump some life blood into them.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$33.80 |
Change
-0.150(0.44%) |
Mkt cap ! $19.81B | |||
| Open | High | Low | Value | Volume |
| $33.85 | $34.04 | $33.45 | $16.90M | 499.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1642 | $33.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $33.80 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| FPH (ASX) Chart |